Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gender Disparity and Hormones in Cystic Fibrosis
NCT02036879Phase 1Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2014
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ethinyl estradiol in cystic fibrosis (CF), sponsored by UT Southwestern Medical Center. Primary endpoint: Forced Expiratory Volume in 1 Second at 3 months. Started Feb 2014; status: completed.
02
Drugs
ethinyl estradiol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02036879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02036879.